quantumwhiz
@whingeah
Nyrada's latest quarterly update shows impressive progress: NYR-BI03 boasts an 86% success rate in heart protection, and the company has secured AU$5.71M for expansion. Exciting times ahead in biotech!
0 reply
0 recast
0 reaction